Science 37 Holdings announced a multi-year relationship with Amazon Web Services to scale and accelerate adoption of the Science 37 Metasite, which provides clinical trial sponsors the ability to securely engage with patients beyond traditional clinical trial sites. Science 37 will become a partner in the AWS Partner Network, which will help reach more customers and providers. Science 37 will continue to leverage the security and reliability of AWS, in addition to its analytics and machine learning (ML) services to help improve decision-making, support patient safety, and reduce the length of trial lifecycles.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNCE:
- Science 37 appoints Irena Lambridis global head of quality assurance, compliance
- Science 37 to Host Business Update Call on April 12, 2023
- Science 37 Unveils Three Global Centers of Excellence to Drive Efficiency, Speed and Quality
- Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
- Science 37 price target lowered to $2.50 from $3.00 at TD Cowen